A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo.
Saved in:
| Title: | A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo. |
|---|---|
| Authors: | Filioglou, Dimitrios1 (AUTHOR), Santa-Cruz, Nina1,2 (AUTHOR), Leite, Geovana S. F.1,3 (AUTHOR), Davini, Dan W.1,4 (AUTHOR), Cracchiolo, Megan J.1,5 (AUTHOR), Baker, Forrest L.1,2,3,6 (AUTHOR), Husnain, Muhammad1,3,4 (AUTHOR), Simpson, Richard J.1,2,3,5 (AUTHOR), Voudouris, Vasilios3,6 (AUTHOR), Katsanis, Emmanuel1,3,4,5 (AUTHOR) ekatsani@arizona.edu |
| Source: | Cancers. Jun2025, Vol. 17 Issue 11, p1889. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers17111889 |
